Skip to content

the safety and efficacy of norepinephrine duirng spinal anesthesia for cesarean section

a randomized, double-blinded study of norepinephrine and phenylephrine in the prevention and treatment of maternal hypotension during cesarean section with spinal anesthesia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800016894
Enrollment
Unknown
Registered
2018-07-01
Start date
2018-08-01
Completion date
Unknown
Last updated
2018-07-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal anesthesia for cesaren section

Interventions

norepinephrine group:8ug norepinephrine intravenous bolus
phenylephrine group:100ug phenylephrine intravenous bolus

Sponsors

Department of anesthesiology, Obstetric and Gynecology Hospital Affiliated to Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: We enrolled parturients according to the following criteria: ASA I or II, primiparity, singleton, term pregnancy, elective surgery, and scheduled for spinal anesthesia. Eligible subjects were invited to participate in the study immediately after entering into the operating room. All enrolled subjects signed an individual informed consent before spinal anesthesia.

Exclusion criteria

Exclusion criteria: Subjects with one or more of the following characteristics were excluded from the study: younger than 18 or older than 45; weight less than 50kg or more than 100kg; height lower than 140cm or higher than 180cm; multiparous women; twin gestation; suspected compromised fetus; concurrent with preexisting hypertension or pregnancy related hypertension; comorbid with pregnancy related diabetes; comorbid with cardiovascular or cerebrovascular disease; diagnosed as depression or anxiety during pregnancy; occurrence of intraoperative shivering; patients taking monoamine oxidase inhibitors, serotonin reuptake inhibitor, or tricyclic antidepressant; failure in spinal anesthesia. Of note, for those who are not willing to participate in the study, standard obstetric anesthesia and operational procedures were applied as well, however, the corresponding data will not be collected.

Design outcomes

Primary

MeasureTime frame
incidence of hypotension;cardiac strove volume;cardiac output;

Secondary

MeasureTime frame
neonatal Apgar score;neonatal neurobehavioral score;neonatal blood gas analysis;

Countries

China

Contacts

Public ContactShiqin Xu

Obstetric and Gynecology Hospital Affiliated to Nanjing Medical University

xusqnj@126.com+86 13951660028

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026